- Home
- ALX vs OPK Comparison
ALX vs OPK Comparison
Compare ALX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALX
- OPK
- Stock Information
- Founded
- ALX 1928
- OPK 2007
- Country
- ALX United States
- OPK United States
- Employees
- ALX N/A
- OPK N/A
- Industry
- ALX Real Estate Investment Trusts
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- ALX Real Estate
- OPK Health Care
- Exchange
- ALX Nasdaq
- OPK Nasdaq
- Market Cap
- ALX 1.2B
- OPK 1.0B
- IPO Year
- ALX N/A
- OPK 1995
- Fundamental
- Price
- ALX $236.56
- OPK $1.39
- Analyst Decision
- ALX
- OPK Buy
- Analyst Count
- ALX 0
- OPK 4
- Target Price
- ALX N/A
- OPK $2.75
- AVG Volume (30 Days)
- ALX 45.1K
- OPK 1.9M
- Earning Date
- ALX 11-03-2025
- OPK 11-06-2025
- Dividend Yield
- ALX 7.62%
- OPK N/A
- EPS Growth
- ALX N/A
- OPK N/A
- EPS
- ALX 7.28
- OPK N/A
- Revenue
- ALX $218,089,000.00
- OPK $664,029,000.00
- Revenue This Year
- ALX N/A
- OPK N/A
- Revenue Next Year
- ALX N/A
- OPK $0.84
- P/E Ratio
- ALX $33.33
- OPK N/A
- Revenue Growth
- ALX N/A
- OPK N/A
- 52 Week Low
- ALX $184.76
- OPK $1.11
- 52 Week High
- ALX $260.84
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- ALX 52.00
- OPK 51.88
- Support Level
- ALX N/A
- OPK $1.34
- Resistance Level
- ALX $247.42
- OPK $1.44
- Average True Range (ATR)
- ALX 5.45
- OPK 0.04
- MACD
- ALX -7.52
- OPK -0.00
- Stochastic Oscillator
- ALX 95.61
- OPK 50.00
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.